Glypican-3: A new target for cancer immunotherapy
European Journal of Cancer2010Vol. 47(3), pp. 333–338
Citations Over TimeTop 10% of 2010 papers
Related Papers
- → Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma(2015)122 cited
- → Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma(2020)53 cited
- → Usefulness of a novel oncofetal antigen, Glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma(2008)10 cited
- → Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis(2013)18 cited
- Relationship between Glypican-3 and hepatocellular carcinoma(2011)